📑 Table of Contents
- Breast Cancer Treatment Cost in India
- Quick Reference: Breast Cancer Treatment Costs in India by Modality
- Total Treatment Cost by Stage and Receptor Status
- The HER2 Question: Why Receptor Status Changes Your Cost Significantly
- 8 Factors That Determine Your Breast Cancer Treatment Cost
- What Is Typically Included and Excluded in Breast Cancer Treatment Costs
- How to Get an Accurate Breast Cancer Cost Estimate
Breast Cancer Treatment Cost in India
Breast cancer treatment cost in India varies more than most patients expect when they first research it. A patient with early-stage, hormone receptor-positive breast cancer may complete her entire treatment for $8,000–$14,000 in India. A patient with HER2-positive, locally advanced disease requiring surgery, chemotherapy, a year of trastuzumab, and radiation may spend $25,000–$40,000. A patient with metastatic breast cancer on ongoing targeted therapy and immunotherapy may spend $15,000–$30,000 per year, indefinitely.
These are all ‘breast cancer treatment costs in India’ — but they are very different situations. The figures that tend to circulate online are usually drawn from the lowest-cost scenario and presented without that context. This guide breaks down costs accurately, stage by stage and modality by modality, so you can build a realistic estimate for your specific diagnosis.
Quick Reference: Breast Cancer Treatment Costs in India by Modality
All figures in USD. Costs reflect realistic ranges at JCI or NABH-accredited hospitals with dedicated breast oncology programmes.
|
Treatment / Procedure |
India (USD) |
USA (USD) |
UK (USD) |
Saving vs USA |
|
SURGERY |
|
|
|
|
|
Lumpectomy (breast-conserving surgery) |
$2,500–$4,500 |
$15,000–$30,000 |
$8,000–$18,000 |
~85% |
|
Simple Mastectomy |
$3,000–$5,500 |
$18,000–$38,000 |
$10,000–$22,000 |
~86% |
|
Modified Radical Mastectomy (MRM) |
$3,500–$6,500 |
$20,000–$45,000 |
$12,000–$28,000 |
~87% |
|
Sentinel Lymph Node Biopsy |
$600–$1,200 |
$5,000–$12,000 |
$2,500–$7,000 |
~90% |
|
Axillary Lymph Node Dissection |
$800–$1,500 |
$5,000–$14,000 |
$3,000–$8,000 |
~90% |
|
Breast Reconstruction (implant-based) |
$3,000–$6,000 |
$20,000–$45,000 |
$12,000–$30,000 |
~87% |
|
Breast Reconstruction (flap-based, e.g. TRAM / DIEP) |
$5,000–$9,000 |
$25,000–$60,000 |
$15,000–$40,000 |
~83% |
|
CHEMOTHERAPY |
|
|
|
|
|
AC (Adriamycin + Cyclophosphamide) — per cycle |
$300–$600 |
$3,000–$8,000 |
$1,500–$5,000 |
~92% |
|
Docetaxel (Taxotere) — per cycle |
$200–$500 |
$2,500–$7,000 |
$1,200–$4,500 |
~93% |
|
Paclitaxel (Taxol) — per cycle |
$150–$400 |
$2,000–$6,000 |
$1,000–$4,000 |
~93% |
|
Capecitabine (Xeloda) — per cycle (oral) |
$100–$300 |
$1,500–$4,000 |
$800–$2,500 |
~93% |
|
TARGETED THERAPY |
|
|
|
|
|
Trastuzumab / Herceptin (biosimilar) — per cycle |
$400–$900 |
$3,500–$8,000 |
$2,000–$5,000 |
~88% |
|
Trastuzumab (1 year / 17 cycles total) |
$7,000–$15,000 |
$60,000–$130,000 |
$34,000–$80,000 |
~88% |
|
Pertuzumab (Perjeta) — per cycle |
$1,200–$2,500 |
$8,000–$18,000 |
$4,500–$10,000 |
~86% |
|
Palbociclib / CDK4/6 inhibitor — per month (oral) |
$500–$1,200 |
$12,000–$18,000 |
$6,000–$10,000 |
~93% |
|
Fulvestrant / Hormone therapy injections — per month |
$150–$400 |
$1,800–$4,500 |
$900–$2,500 |
~92% |
|
Tamoxifen / Letrozole / Anastrozole — per month (oral) |
$10–$40 |
$200–$600 |
$50–$200 |
~94% |
|
RADIATION THERAPY |
|
|
|
|
|
Whole Breast Radiation (standard, 25–33 fractions) |
$3,500–$6,000 |
$30,000–$55,000 |
$16,000–$35,000 |
~90% |
|
Hypofractionated Radiation (15–16 fractions) |
$2,500–$4,500 |
$22,000–$45,000 |
$12,000–$28,000 |
~89% |
|
IMRT (Intensity-Modulated Radiation) |
$4,000–$7,000 |
$28,000–$55,000 |
$16,000–$35,000 |
~87% |
|
Chest Wall / Post-Mastectomy Radiation |
$3,500–$6,500 |
$28,000–$55,000 |
$16,000–$35,000 |
~89% |
Total Treatment Cost by Stage and Receptor Status
Because breast cancer treatment is multi-modal, the most useful cost figure is the total treatment episode cost — not a single procedure. The table below gives realistic total cost ranges for the most common clinical scenarios:
|
Diagnosis |
Standard Treatment Protocol |
Estimated Total Cost in India (USD) |
|
Stage I — ER+/PR+, HER2− |
Lumpectomy + sentinel node biopsy + radiation (hypofractionated) + 5 years tamoxifen/AI |
$7,000–$12,000 for active treatment; oral hormone therapy ~$120–$480/year ongoing |
|
Stage II — ER+/PR+, HER2− |
Lumpectomy or MRM + 4–6 cycles AC-T chemo + radiation + 5–10 years hormone therapy |
$12,000–$20,000 for active treatment phase |
|
Stage II–III — HER2+ (any hormone status) |
Surgery + 8 cycles AC-T chemo + 17 cycles trastuzumab (1 year) + radiation |
$22,000–$38,000 total (trastuzumab is the largest cost component) |
|
Stage II–III — Triple Negative (ER−/PR−/HER2−) |
Surgery + 6–8 cycles chemotherapy + radiation; pembrolizumab in selected cases |
$13,000–$22,000 without immunotherapy; $25,000–$40,000 if pembrolizumab added |
|
Stage III (Locally Advanced) — Neoadjuvant approach |
Neoadjuvant chemo (6–8 cycles) + surgery + radiation + adjuvant targeted therapy |
$18,000–$35,000 depending on HER2 status and response to neoadjuvant therapy |
|
Stage IV (Metastatic) — ER+/HER2− |
CDK4/6 inhibitor (palbociclib) + fulvestrant or AI; ongoing until progression |
$9,000–$20,000 per year (highly variable; continues until disease progression) |
|
Stage IV (Metastatic) — HER2+ |
Trastuzumab + pertuzumab + docetaxel (first line); subsequent lines on progression |
$25,000–$50,000 per year for first-line; subsequent lines vary |
|
Stage IV (Metastatic) — Triple Negative |
Pembrolizumab + chemotherapy (if PD-L1+); capecitabine or other agents |
$20,000–$45,000 per year depending on regimen |
The HER2 Question: Why Receptor Status Changes Your Cost Significantly
Of all the variables that affect breast cancer treatment cost, HER2 status is the most significant single factor after disease stage. Understanding why helps you plan more accurately.
HER2-Negative Disease (ER+ or Triple Negative)
For hormone receptor-positive, HER2-negative breast cancer, the active treatment phase involves surgery, chemotherapy (where indicated by stage and tumour biology), and radiation. These are all generic or low-cost drug-based treatments in India. The ongoing cost is oral hormone therapy — tamoxifen or aromatase inhibitors — which costs $10–$40 per month in India. Total treatment cost for early-stage ER+/HER2− disease is the lowest among breast cancer subtypes.
HER2-Positive Disease
HER2-positive breast cancer requires anti-HER2 targeted therapy — most commonly trastuzumab (Herceptin) for one year following surgery and chemotherapy. In India, trastuzumab biosimilars are available and are clinically equivalent to originator Herceptin. A full year of trastuzumab (17 cycles at 3-weekly intervals) costs $7,000–$15,000 in India, compared to $60,000–$130,000 in the United States. This single treatment component represents the largest cost difference between HER2+ and HER2− breast cancer treatment.
For high-risk HER2+ disease or metastatic HER2+ cancer, pertuzumab (Perjeta) may be added alongside trastuzumab, doubling the targeted therapy cost. Confirm whether your oncologist recommends dual anti-HER2 blockade — it is clinically indicated in specific situations and significantly changes the cost picture.
Triple Negative Breast Cancer
Triple negative breast cancer (ER−, PR−, HER2−) has no hormone receptor or HER2 to target, which historically made it reliant on chemotherapy alone. The addition of pembrolizumab (Keytruda) immunotherapy for PD-L1-positive, early triple negative breast cancer is now standard of care in many guidelines, following the KEYNOTE-522 trial. This adds the cost of checkpoint inhibitor immunotherapy to the treatment plan. In India, pembrolizumab for TNBC costs $1,500–$3,500 per cycle; the protocol involves 8 cycles alongside chemotherapy plus a further 9 cycles as single agent post-surgery. This is a meaningful cost addition — budget for it if your oncologist indicates it.
8 Factors That Determine Your Breast Cancer Treatment Cost
|
Stage at Diagnosis Stage I disease requiring only surgery and radiation costs $7,000–$12,000 in total. Stage IV metastatic disease requiring ongoing systemic therapy may cost $15,000–$50,000 per year. Stage is the primary cost driver. |
|
HER2 Status HER2-positive disease adds $7,000–$30,000+ to treatment cost due to anti-HER2 targeted therapy requirements. This is the most significant molecular variable for treatment cost. |
|
Surgical Approach: Lumpectomy vs Mastectomy Breast-conserving surgery (lumpectomy) costs less than mastectomy but typically requires radiation. Mastectomy avoids radiation in many cases but has a higher surgical cost and, if reconstruction is chosen, adds $3,000–$9,000. The clinical decision between lumpectomy and mastectomy is made by your surgeon based on tumour size, location, and your preference. |
|
Breast Reconstruction Choice Implant-based reconstruction ($3,000–$6,000) costs less than autologous flap reconstruction ($5,000–$9,000) but has different long-term outcomes. Reconstruction is an elective component of treatment cost that depends entirely on the patient’s preference and the surgeon’s clinical assessment of suitability. |
|
Chemotherapy Regimen Not all breast cancer patients require chemotherapy. For small, low-grade, hormone receptor-positive tumours, oncotype DX or similar genomic tests may indicate that chemotherapy provides minimal benefit. Where chemotherapy is indicated, the regimen (AC-T, TC, CMF) determines cost per cycle and the number of cycles. |
|
Radiation: Technique and Fractionation Standard whole breast radiation (25–33 fractions) costs more than hypofractionated radiation (15–16 fractions) which delivers higher doses per session over fewer sessions. Hypofractionation is now the standard for many early breast cancers and costs $2,500–$4,500 vs $3,500–$6,000 for standard fractionation. |
|
Duration of Hormone Therapy Oral hormone therapy (tamoxifen or aromatase inhibitors) continues for 5–10 years post-treatment. At $10–$40 per month in India, this is a very low ongoing cost. However, if CDK4/6 inhibitors such as palbociclib are added for metastatic ER+ disease, monthly costs rise to $500–$1,200. |
|
Hospital Tier and City Top-tier JCI and NABH-accredited breast oncology centres in Delhi, Mumbai, and Bangalore are at the upper end of the cost range. Leading hospitals in Chennai, Hyderabad, and Chandigarh often offer equivalent clinical standards at 10–20% lower cost. The quality of the breast oncology team matters more than the city. |
What Is Typically Included and Excluded in Breast Cancer Treatment Costs
|
Generally Included per Episode |
Often Billed Separately |
|
Surgical procedure, anaesthesia, OT charges |
Pre-treatment diagnostic workup: biopsy, MRI, mammogram, ultrasound |
|
Hospital stay for surgical episodes |
Hormone receptor and HER2 testing (IHC / FISH) |
|
Chemotherapy drugs and administration per cycle session |
Oncotype DX or genomic profiling tests ($800–$2,500) |
|
Radiation course (when booked as full course) |
Anti-emetics, growth factors, and supportive drugs during chemo |
|
Inpatient nursing during admissions |
BRCA1/BRCA2 genetic testing if indicated ($200–$600) |
|
Discharge summary and complete medical records |
Fertility preservation (egg banking) if applicable before chemotherapy |
|
Oncologist consultation during treatment cycle visits |
Reconstructive implants for breast reconstruction (priced separately) |
|
Ask for a Multi-Modality Cost Breakdown For breast cancer, cost planning requires a breakdown across all modalities — surgery, chemotherapy cycles and regimen, radiation fractionation, targeted therapy (with specific drug and duration), and ongoing hormone therapy. A single ‘package’ price rarely covers this comprehensively. Request a written breakdown that specifies each component so you can plan your total treatment budget accurately. |
How to Get an Accurate Breast Cancer Cost Estimate
- Gather your complete pathology and diagnostic file: biopsy report with receptor status (ER, PR, HER2 by IHC and FISH if HER2 2+), staging CT or PET-CT, breast MRI if available, mammogram and ultrasound reports
- Share reports for an oncologist review before requesting cost. A breast oncologist reviewing your pathology can confirm the treatment protocol appropriate for your specific subtype and stage, which is the only basis for a meaningful cost estimate
- Ask specifically which chemotherapy regimen is recommended, how many cycles, and whether neoadjuvant (before surgery) or adjuvant (after surgery) chemotherapy is planned
- Confirm HER2 status if not already tested — this single result changes your total treatment cost by $7,000–$30,000
- If you are considering breast reconstruction, ask your surgeon to quote this separately and to specify the technique (implant or flap) and the associated implant cost
- For post-menopausal patients or those considering aromatase inhibitors, confirm whether an initial bone density scan is recommended, as AI therapy can affect bone density and monitoring adds cost
- Arrange a video consultation with the breast oncologist before committing to travel. This allows a direct clinical discussion and often produces a more accurate estimate than what a coordinator provides remotely
|
Get a Case-Specific Breast Cancer Treatment Cost Estimate Breast cancer treatment cost in India depends on your stage, receptor status, surgical choice, and treatment protocol. A general range tells you the order of magnitude. A case-specific estimate — based on your pathology, HER2 status, and staging — tells you what your treatment will actually cost. Share your biopsy reports, receptor status, and staging scans with our team. A matched breast oncologist will review your case and provide a written treatment plan and modality-by-modality cost estimate — at no charge, with no obligation to proceed. Free. Confidential. Reports reviewed within 24–48 hours. | www.racurehealthcare.com |
🫀 Need Expert Cardiac Care?
Our experienced cardiac surgeons can help you understand your options and plan the best treatment.